Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Journal of Biological Chemistry
|
September 25, 2009
Improved binding of raf to Ras.GDP is correlated with biological activity
Christina Kiel, Daniel Filchtinski, Michael Spoerner, et al.
Bioconjugate Chemistry
|
August 21, 2008
Probing ras effector interactions on nanoparticle supported lipid bilayers
Daniel Filchtinski, Christine Bee, Tudor Savopol, et al.
Journal of Molecular Biology
|
April 6, 2010
What makes Ras an efficient molecular switch: a computational, biophysical, and structural study of Ras-GDP interactions with mutants of Raf
Daniel Filchtinski, Oz Sharabi, Alma Rüppel, et al.
Journal of Immunological Methods
|
May 30, 2025
Development and performance evaluation of a novel, fully automated, high-throughput GAD65 autoantibody assay on the Phadia platform
Daniel Filchtinski, José Kayser, Virginie Ettner, et al.
Biochemistry
|
May 29, 2014
Elucidating the mode of action of a typical Ras state 1(T) inhibitor
Ina C Rosnizeck, Daniel Filchtinski, Rui Pedro Lopes, et al.
Angewandte Chemie (International Ed. in English)
|
September 22, 2012
Metal-bis(2-picolyl)amine complexes as state 1(T) inhibitors of activated Ras protein
Ina C Rosnizeck, Michael Spoerner, Tobias Harsch, et al.
Journal of Immunological Methods
|
March 19, 2022
Application of the SARS-CoV-2-S1 ACE-2 receptor interaction as the basis of the fully automated assay to detect neutralizing SARS-CoV-2-S1 antibodies in blood samples
Daniel Filchtinski, Magnus Sundberg, Heike Berthold, et al.
Angewandte Chemie (International Ed. in English)
|
April 20, 2010
Stabilizing a weak binding state for effectors in the human ras protein by cyclen complexes
Ina C Rosnizeck, Thorsten Graf, Michael Spoerner, et al.
Plos One
|
November 29, 2021
Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches
Sara Stinca, Thomas W Barnes, Peter Vogel, et al.
Clinical Immunology (Orlando, Fla.)
|
October 7, 2021
Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors
Thomas W Barnes, Johannes Schulte-Pelkum, Laura Steller, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Journal of Biological Chemistry
|
September 25, 2009
Improved binding of raf to Ras.GDP is correlated with biological activity
Christina Kiel, Daniel Filchtinski, Michael Spoerner, et al.
Bioconjugate Chemistry
|
August 21, 2008
Probing ras effector interactions on nanoparticle supported lipid bilayers
Daniel Filchtinski, Christine Bee, Tudor Savopol, et al.
Journal of Molecular Biology
|
April 6, 2010
What makes Ras an efficient molecular switch: a computational, biophysical, and structural study of Ras-GDP interactions with mutants of Raf
Daniel Filchtinski, Oz Sharabi, Alma Rüppel, et al.
Journal of Immunological Methods
|
May 30, 2025
Development and performance evaluation of a novel, fully automated, high-throughput GAD65 autoantibody assay on the Phadia platform
Daniel Filchtinski, José Kayser, Virginie Ettner, et al.
Biochemistry
|
May 29, 2014
Elucidating the mode of action of a typical Ras state 1(T) inhibitor
Ina C Rosnizeck, Daniel Filchtinski, Rui Pedro Lopes, et al.
Angewandte Chemie (International Ed. in English)
|
September 22, 2012
Metal-bis(2-picolyl)amine complexes as state 1(T) inhibitors of activated Ras protein
Ina C Rosnizeck, Michael Spoerner, Tobias Harsch, et al.
Journal of Immunological Methods
|
March 19, 2022
Application of the SARS-CoV-2-S1 ACE-2 receptor interaction as the basis of the fully automated assay to detect neutralizing SARS-CoV-2-S1 antibodies in blood samples
Daniel Filchtinski, Magnus Sundberg, Heike Berthold, et al.
Angewandte Chemie (International Ed. in English)
|
April 20, 2010
Stabilizing a weak binding state for effectors in the human ras protein by cyclen complexes
Ina C Rosnizeck, Thorsten Graf, Michael Spoerner, et al.
Plos One
|
November 29, 2021
Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches
Sara Stinca, Thomas W Barnes, Peter Vogel, et al.
Clinical Immunology (Orlando, Fla.)
|
October 7, 2021
Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors
Thomas W Barnes, Johannes Schulte-Pelkum, Laura Steller, et al.
Page
of 1